These loss-of-function RasGRP1 mutants lead to the development of autoimmune lymphoproliferative syndrome (ALPS), CD4+ T cell lymphopenia, recurrent infections, hepatosplenomegaly, and lymphadenopathy [75,76,77]. This evidence concerns the gene CD4 and autoimmune lymphoproliferative syndrome.